Iovance Biotherapeutics, Inc. Equity-NMS: IOVA

$6.07 0.39 (December 1, 2023)

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$5.68
Open :$5.91
Today's high :$6.58
Today's low :$5.84
52W low :$3.21
52W high :$9.36
1Y :-12.68%
5Y :-44.1%
Shares O/S :255.92 M
Market cap :1.55 B

Compare with Other Stocks

Frequently Asked Questions

What is the share price of Iovance Biotherapeutics, Inc. today?

Iovance Biotherapeutics, Inc. (IOVA) share price as of December 1, 2023, is $6.07. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Iovance Biotherapeutics, Inc.?

Yes, Indian Investors can invest in the Iovance Biotherapeutics, Inc. (IOVA) Share by opening an international trading account with Angel One.

How can I purchase Iovance Biotherapeutics, Inc. shares in India?

Purchasing Iovance Biotherapeutics, Inc. (IOVA) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying Iovance Biotherapeutics, Inc. (IOVA) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Iovance Biotherapeutics, Inc.?

Yes, you can purchase fractional shares of Iovance Biotherapeutics, Inc. (IOVA) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Iovance Biotherapeutics, Inc.?

The market capitalization of Iovance Biotherapeutics, Inc. on December 1, 2023, is $1.55 B.

In which sector Iovance Biotherapeutics, Inc. belongs?

Iovance Biotherapeutics, Inc. operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Iovance Biotherapeutics, Inc. stocks?

In order to invest in Iovance Biotherapeutics, Inc. (IOVA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company, which commercializes autologous T-cell therapy to address solid tumor cancer. It develops and delivers tumor infiltrating lymphocyte (TIL), therapies for patients with solid tumor cancers. Its lead product candidate, lifileucel, is being developed in advanced, or metastatic or unresectable, melanoma, as well as in other indications. Lifileucel is investigated in two consecutive cohorts in a clinical trial of advanced melanoma patients post-anti-PD-1 therapy, including in a prospectively defined pivotal cohort. It has initiated Phase III clinical trial of lifileucel in combination with pembrolizumab, TILVANCE-301. The Company is also pursuing registrational strategies for lifileucel in advanced cervical cancer and for its TIL therapy, LN-145, in metastatic non-small cell lung cancer. Its first genetically modified, PD-1 inactivated TIL therapy, IOV-4001, is under Phase I/II clinical trial, IOV-GM1-201.